Chemokine-Ligands/Receptors: Multiplayers in Traumatic Spinal Cord Injury

by Friederike Knerlich-Lukoschus, Janka Held-Feindt
Published 2015-01-01

Insights into Gene Regulation under Temozolomide-Promoted Cellular Dormancy and Its Connection to Stemness in Human Glioblastoma

by Carolin Kubelt, Dana Hellmold, Daniela Esser, Hajrullah Ahmeti, Michael Synowitz, Janka Held-Feindt
Published 2023-05-01

The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16

by Vivian Adamski, Rolf Mentlein, Ralph Lucius, Michael Synowitz, Janka Held-Feindt, Kirsten Hattermann
Published 2017-07-01

Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche

by Deniz Caylioglu, Rieke Johanna Meyer, Dana Hellmold, Carolin Kubelt, Michael Synowitz, Janka Held-Feindt
Published 2021-03-01

Modeling treatment-dependent glioma growth including a dormant tumor cell subpopulation

by Marvin A. Böttcher, Janka Held-Feindt, Michael Synowitz, Ralph Lucius, Arne Traulsen, Kirsten Hattermann
Published 2018-04-01

Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling

by Kirsten Hattermann, Henrike Gebhardt, Sebastian Krossa, Andreas Ludwig, Ralph Lucius, Janka Held-Feindt, Rolf Mentlein
Published 2016-01-01

Evaluation of a Brown Seaweed Extract from <em>Dictyosiphon foeniculaceus</em> as a Potential Therapeutic Agent for the Treatment of Glioblastoma and Uveal Melanoma

by Philipp Dörschmann, Christina Schmitt, Kaya Saskia Bittkau, Sandesh Neupane, Michael Synowitz, Johann Roider, Susanne Alban, Janka Held-Feindt, Alexa Klettner
Published 2020-12-01

Intratumoral Distribution of Lactate and the Monocarboxylate Transporters 1 and 4 in Human Glioblastoma Multiforme and Their Relationships to Tumor Progression-Associated Markers

by Carolin Kubelt, Sönke Peters, Hajrullah Ahmeti, Monika Huhndorf, Lukas Huber, Gesa Cohrs, Jan-Bernd Hövener, Olav Jansen, Michael Synowitz, Janka Held-Feindt
Published 2020-08-01

Fabrication and Modelling of a Reservoir-Based Drug Delivery System for Customizable Release

by Margarethe Hauck, Jan Dittmann, Berit Zeller-Plumhoff, Roshani Madurawala, Dana Hellmold, Carolin Kubelt, Michael Synowitz, Janka Held-Feindt, Rainer Adelung, Stephan Wulfinghoff, Fabian Schütt
Published 2022-04-01

Establishment of a Rodent Glioblastoma Partial Resection Model for Chemotherapy by Local Drug Carriers—Sharing Experience

by Carolin Kubelt, Dana Hellmold, Eva Peschke, Margarethe Hauck, Olga Will, Fabian Schütt, Ralph Lucius, Rainer Adelung, Regina Scherließ, Jan-Bernd Hövener, Olav Jansen, Michael Synowitz, Janka Held-Feindt
Published 2023-05-01

Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells

by Dana Hellmold, Carolin Kubelt, Tina Daunke, Silje Beckinger, Ottmar Janssen, Margarethe Hauck, Fabian Schütt, Rainer Adelung, Ralph Lucius, Jochen Haag, Susanne Sebens, Michael Synowitz, Janka Held-Feindt
Published 2023-05-01

In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment

by Guranda Chitadze, Charlotte Flüh, Elgar Susanne Quabius, Sandra Freitag-Wolf, Christian Peters, Marcus Lettau, Jaydeep Bhat, Daniela Wesch, Hans-Heinrich Oberg, Stefanie Luecke, Ottmar Janssen, Michael Synowitz, Janka Held-Feindt, Dieter Kabelitz
Published 2017-11-01